Month: March 2014

On March 27, we have issued an updated research report on Walter Energy, Inc. ( WLT ). The U.S. […]

On Mar 27, 2014, we issued an updated research report on Mattel, Inc. ( MAT ). On Jan 31, this leading toy maker reported dismal fourth quarter results with earnings and revenue missing the Zacks Consensus Estimate […]

On March 28, 2014, we issued an updated research report on Raytheon Company ( RTN ). This defense major surpassed the Street consensus in its fourth quarter 2013 earnings release. For the last four quarters the company came out with higher-than-expected earnings with an average surprise of approximately 19.7%. […]

Endocyte, Inc. ( ECYT ) shares fell 4.8% following the announcement of its intention to issue shares and the pricing of the underwritten public offering of its common stock. The company is looking to issue 4.5 million shares at $21 per share. […]

MannKind Corp. ’s ( MNKD ) shares were down more than 7% following the release of briefing documents ahead of an FDA advisory panel meeting where the company’s diabetes candidate, Afrezza (inhaled insulin) will be reviewed. The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee meeting is scheduled for Apr 1. […]

Zacks Investment Research downgraded John Bean Technologies Corporation ( JBT ) to a Zacks Rank #5 (Strong Sell) on Mar 29, 2014. Going by the Zacks model, companies with a Zacks Rank #5 have strong chances of performing worse than the broader market. […]

Idera Pharmaceuticals, Inc. ( IDRA ) shares jumped 17.78% after the company announced positive top-line data from a phase II study on its lead pipeline candidate, IMO-8400, an antagonist of toll-like receptors (TLRs) 7, 8, and 9. The randomized, double-blind, placebo controlled phase II study (n = 32) assessed the safety and tolerability (primary objective) of IMO-8400 (at dose levels of 0.075 mg/kg, 0.15 mg/kg and 0.3 mg/kg) versus placebo in patients suffering from moderate-to-severe plaque psoriasis over 12 weeks […]

Shares of Covidien plc ( COV ) hit a new 52-week high of $73.39 in mid-day trading on Mar 28 eventually closing at $72.50. In fact, shares of this Ireland-based medical products company have been gaining momentum since it reported better-than-expected fiscal first-quarter 2014 results on Jan 24. Year to date, the company's share price has recorded a healthy return of 22.8% […]

It seems Delta Airlines Inc. ( DAL ) is reaping the benefits of its tie up with Virgin Atlantic as it is picking up in the New York-London travel route − one of the world’s popular itineraries. Looking back, in Jun 2013, Delta acquired a 49% stake in British carrier Virgin Atlantic from Singapore Airlines […]

Shares of ABB Ltd. ( ABB ) increased 1.5% on March 28, following the company’s announcement of receiving a contract from a leading Italian multi-utility firm – ACEA (Azienda Comunale Elettricità e Acque) – for developing a smart electricity distribution system in parts of Rome. Prior to this, ABB and ACEA had joined forces to conduct a series of experiments on portions of electrical grids in Rome to gain deeper insight into requirements of low and medium voltage products in the city […]

Smith & Wesson Holding Corporation ( SWHC ) announced that its board of directors authorized the repurchase of $30.0 million of the company’s common stock. The company expects to start the latest share buyback program no sooner than the beginning of fiscal 2015 (May 1, 2014). In the third quarter fiscal 2014 the company used $15.3 million in cash from financing activities, mainly for its stock repurchase program […]

Metal processor Worthington Industries, Inc. ( WOR ) has entered into an agreement with Steffes Corporation to acquire its tank manufacturing division for an undisclosed price. […]

Anacor Pharmaceuticals, Inc. ( ANAC ) enrolled the first patient in a phase III study on its atopic dermatitis candidate, AN2728, for the topical treatment of mild-to-moderate atopic dermatitis. The phase III trials comprise two multi-center, double-blind, randomized (2: 1 ), placebo-controlled studies enrolling roughly 750 patients (two years and above) each. […]

Cerner Corporation ( CERN ) and medical software developer OTTR (Organ Transplant Tracking Record) Chronic Care Solutions have joined hands to integrate their products and services to improve the workflows and processes required to support organ, blood and marrow transplant care delivery teams. However, the news failed to entice investors as shares slid 0.7% following the announcement. Currently, OTTR is the leading patient tracking application and patient record system specifically tailored for solid organ transplant centers and CERN will be the only electronic health record provider to offer it. […]

Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight into the commercial potential of the candidate once it is successfully developed and commercialized. […]